Search

Your search keyword '"Allergan Inc. -- Product information -- 00004163"' showing total 1 results
Start Over Descriptor "Allergan Inc. -- Product information -- 00004163" Journal pr newswire
1 results on '"Allergan Inc. -- Product information -- 00004163"'

1. INVESTIGATORS PRESENT PHASE 1-2A DATA AT ASCO ON ALLERGAN-LIGAND FIRST COMPOUND, LGD1057 (ALRT1057) PHASE 2B EFFICACY TRIALS INITIATED

Subjects
Ligand Pharmaceuticals Inc. -- Product information -- 00255141, Allergan Inc. -- Product information -- 00004163, Pharmaceutical industry -- Product information, Antineoplastic agents -- Testing, Business, News, opinion and commentary, Memorial Sloan-Kettering Cancer Center -- Research
Abstract

SAN DIEGO and IRVINE, Calif., May 23 /PRNewswire/ -- Investigators from Memorial Sloan-Kettering Cancer Center (MSKCC) reported results of their Phase 1-2a single daily dose trial with Oral LGD1057 (ALRT1057), [...]

Published
1995

Catalog

Books, media, physical & digital resources
See catalog results